Evidence map›Paper›PMID 29699632›Full record

ArticleThe Kaohsiung journal of medical sciences2018

Mulberry anthocyanins improves thyroid cancer progression mainly by inducing apoptosis and autophagy cell death.

Hou-Long Long, Feng-Feng Zhang, Hong-Ling Wang, Wen-Shi Yang, Hai-Tao Hou, Jing-Kui Yu, Bin Liu

Open access · goldAbstract read
In one paragraph

Article in The Kaohsiung journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Anthocyanins fromEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hou-Long LongDepartment of Breast and Thyroid Surgery, Tengzhou Central People's Hospital, Tengzhou City, Shangdong Province, PR China.
Feng-Feng ZhangDepartment of Breast and Thyroid Surgery, Tengzhou Central People's Hospital, Tengzhou City, Shangdong Province, PR China.
Hong-Ling WangDepartment of Ultrasound Tengzhou Central People's Hospital, Tengzhou City, Shangdong Province, PR China.
Wen-Shi YangDepartment of Breast and Thyroid Surgery, Tengzhou Central People's Hospital, Tengzhou City, Shangdong Province, PR China.
Hai-Tao HouDepartment of Breast and Thyroid Surgery, Tengzhou Central People's Hospital, Tengzhou City, Shangdong Province, PR China.
Jing-Kui YuDepartment of Breast and Thyroid Surgery, Tengzhou Central People's Hospital, Tengzhou City, Shangdong Province, PR China.
Bin LiuDepartment of Breast and Thyroid Surgery, Tengzhou Central People's Hospital, Tengzhou City, Shangdong Province, PR China. Electronic address: liubin7777@126.com.
Tengzhou Central People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dietary anthocyanin compounds have multiple biological effects, including antioxidant, anti-inflammatory, and anti-atherosclerotic characteristics. The present study evaluated the anti-tumor capacity of mulberry anthocyanins (MA) in thyroid cancer cells. Our data showed that MA suppressed SW1736 and HTh-7 cell proliferation in a time- and dose-dependent manner. Meanwhile, flow cytometry results indicated that MA significantly increased SW1736 and HTh-7 cell apoptosis. We additionally observed that SW1736 and HTh-7 cell autophagy was markedly enhanced after MA treatment. Importantly, anthocyanin-induced cell death was largely abolished by 3-methyladenine (3-MA) or chloroquine diphosphate salt (CQ) treatment, suggesting that MA-induced SW1736 and HTh-7 cell death was partially dependent on autophagy. In addition, activation of protein kinase B (Akt), mammalian target of rapamycin (mTOR), and ribosomal protein S6 (S6) were significantly suppressed by anthocyanin exposure. In summary, MA may serve as an adjunctive therapy for thyroid cancer patients through induction of apoptosis and autophagy-dependent cell death.

Indexed as

Gene Expression Regulation, NeoplasticAdenineAnthocyaninsAntineoplastic Agents, PhytogenicApoptosisAutophagyCell Line, TumorCell ProliferationChloroquineDose-Response Relationship, DrugHumansMorusPlant ExtractsProto-Oncogene Proteins c-aktRibosomal Protein S6Signal Transduction3-methyladenineAdenineAnthocyaninsAntineoplastic Agents, PhytogenicChloroquinechloroquine diphosphateMTOR protein, humanPlant ExtractsProto-Oncogene Proteins c-aktRibosomal Protein S6TOR Serine-Threonine KinasesApoptosisAutophagic deathMulberry anthocyaninsThyroid cancer

Identifiers

PMID29699632
PMCPMC11915611
OpenAlexW2772325305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.